Serious outbreak of human metapneumovirus in patients with hematologic malignancies

Leukemia and Lymphoma

Volumn 57, Issue 3, 2016, Pages 623-627

  Hoellein, Alexander ^a   Hecker, Judith ^a   Hoffmann, DIeter ^a   Göttle, Franziska ^b   Protzer, Ulrike ^a   Peschel, Christian ^a   Götze, Katharina ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

AML; Fatal; Hematologic patients; Human metapneumovirus

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CD4 CD8 RATIO; CELLULAR IMMUNITY; CLINICAL ARTICLE; EPIDEMIC; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPROMIZED PATIENT; LIVER TOXICITY; LUNG LAVAGE; MALE; MOLECULAR DIAGNOSIS; MULTIPLE ORGAN FAILURE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SIDE EFFECT; VIRUS LOAD; ADVERSE EFFECTS; COMPLICATION; CROSS INFECTION; DNA SEQUENCE; GENETICS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; METAPNEUMOVIRUS; MIDDLE AGED; PARAMYXOVIRIDAE INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTIVIRAL AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METAPNEUMOVIRUS; MIDDLE AGED; PARAMYXOVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84945217703     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2015.1067699     Document Type: Article

References (24)

1. Principi N, Esposito S. Paediatric human metapneumovirus infection: epidemiology, prevention and therapy. J Clin Virol 2014; 59: 141-147.
2. Centers for Disease C, Prevention. Outbreaks of human metapneumovirus in two skilled nursing facilities-West Virginia and Idaho, 2011-2012. MMWR Morb Mortal Wkly Rep 2013;62: 909-913.
3. Chu HY, Renaud C, Ficken E, et al. Respiratory tract infections due to human metapneumovirus in immunocompromised children. J Pediatric Infect Dis Soc 2014; 3: 286-293.
4. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-724.
5. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004; 350: 443-450.
6. Broor S, Bharaj P, Chahar HS. Human metapneumovirus: a new respiratory pathogen. J Biosci 2008; 33: 483-493.
7. Williams JV, Martino R, Rabella N, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 2005; 192: 1061-1065.
8. Kamboj M, Gerbin M, Huang CK, et al. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect 2008; 57: 464-471.
9. Renaud C, Xie H, Seo S, et al. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 2013; 19: 1220-1226.
10. Englund JA, Boeckh M, Kuypers J, et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006; 144: 344-349.
11. Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28: 2731-2739.
12. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-4680.
13. Egli A, Bucher C, Dumoulin A, et al. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection 2012; 40: 677-684.
14. Bonney D, Razali H, Turner A, et al. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. Br J Haematol 2009; 145: 667-669.
15. Choudhary ML, Anand SP, Sonawane NS, et al. Development of real-time RT-PCR for detection of human metapneumovirus and genetic analysis of circulating strains (2009-2011) in Pune, India. Arch Virol 2014; 159: 217-225.
16. Viazov S, Ratjen F, Scheidhauer R, et al. High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol 2003; 41: 3043-3045.
17. Reiche J, Jacobsen S, Neubauer K, et al. Human metapneumovirus: insights from a ten-year molecular and epidemiological analysis in Germany. PLoS One 2014; 9: e88342.
18. Leclair JM, Freeman J, Sullivan BF, et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317: 329-334.
19. Walker E, Ison MG. Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza Other Respir Viruses 2014; 8: 282-292.
20. Godet C, Le Goff J, Beby-Defaux A, et al. Human metapneumovirus pneumonia in patients with hematological malignancies. J Clin Virol 2014; 61: 593-596.
21. Matsuda S, Nakamura M, Hirano E, et al. Characteristics of human metapneumovirus infection prevailing in hospital wards housing patients with severe disabilities. Jpn J Infect Dis 2013; 66: 195-200.
22. Vicente D, Montes M, Cilla G, et al. Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clin Infect Dis 2006; 42: e111-113.
23. Kahn JS. Newly discovered respiratory viruses: significance and implications. Curr Opin Pharmacol 2007; 7: 478-483.
24. Ulbrandt ND, Ji H, Patel NK, et al. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J Virol 2006; 80: 7799-7806.